Palvella Therapeutics (PVLA) Invested Capital (2013 - 2026)

Palvella Therapeutics (PVLA) has reported Invested Capital for 2 consecutive years, with $1.3 million the latest figure, recorded in Q4 2014.

• In Q4 2014, Invested Capital rose 515.33% year-over-year to $1.3 million; the TTM figure through Sep 2015 stood at $1.3 million (up 503.79% YoY), while the FY2014 annual figure was $1.3 million, up 515.33% from the prior year.
• Invested Capital advanced to $1.3 million in Q4 2014 per PVLA's latest filing, from $3474.0 in the prior quarter.
• Across five years, Invested Capital topped out at $1.3 million in Q4 2014 and bottomed at $474.0 in Q2 2014.